Cleanzine: your weekly cleaning and hygiene industry newsletter 28th November 2024 Issue no. 1140
Your industry news - first
The original and best - for over 20 years!
We strongly recommend viewing Cleanzine full size in your web browser. Click our masthead above to visit our website version.
AsepticSure disinfection system introduced to Nordic Region
AsepticSure, said to be the only disinfection system in the world that routinely achieves a minimum microbial kill of at least a thousand times greater than conventional cleaning methods, is to be distributed in the Nordic Region by GYD S.A.
The news comes following an agreement by AsepticSure's manufacturer Medizone International, and Aglon a/s, announced on Tuesday. Medizone has granted Aglon exclusive distribution rights for the AsepticSure system in Norway, Sweden, Denmark, Finland and Iceland.
Medizone developed the AsepticSure System to combine oxidative compounds (O3 and H202) to produce a unique mixture of free radicals (H2O3 known as trioxidane) with much higher oxidative potential than ozone or hydrogen peroxide alone. After securing broad IP protection for the use of trioxidane for both healthcare and non-healthcare facility disinfecting systems and bioterrorism applications, Medizone released its AsepticSure System for use in Canada and several other global markets, through its expanding distributor network.
The System is EPA-approved, received the CE mark and is currently pursuing FDA 510(k) registration.
"We are very pleased to expand our distribution network with the addition of Aglon as our exclusive distributor in the Nordic Region," says Medizone's CEO, David A. Dodd. "We are confident that Aglon has the ability and commitment to successfully commercialise AsepticSure in this important market.
"With our recent receipt of the EU CE Mark designation for AsepticSure, we are looking forward to expanding our distributor relationships throughout the EU."
Aglon's CEO Bent Rørvik and chairman Stein I. Modahl, M.D. say they are "proud and excited to spearhead Medizone International's introduction to the European market.
"Through this agreement to represent and market Medizone International's unique sterilisation technology in the Nordic countries, we hope to play a central part in building continued success for the AsepticSure system, both in medical and non-medical markets.
"We have eagerly awaited this opportunity and are ready to proceed towards a successful commercialisation of the AsepticSure system."
2nd November 2017